Trial Profile
A Phase 1 Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects A Single Centre, Randomised, Controlled, Investigator Blinded Study With Intra-individual Comparison of the Active Formulation and Its Components
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Feb 2016
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Psoriasis
- Focus Adverse reactions
- Sponsors LEO Pharma
- 29 Aug 2011 New trial record